Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10018464HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10019018HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10020203HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10020355HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10041510HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10041511HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10044221HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10044222HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10048986HBVENSG00000163631.19protein_codingALBNoNo213P02768
TVIS10048987HBVENSG00000163631.19protein_codingALBNoNo213P02768
TCGA Plot Options
Drug Information
GeneALB
DrugBank IDDB00276
Drug NameAmsacrine
Target IDBE0000530
UniProt IDP02768
Regulation Type
PubMed IDs10803926
CitationsFinlay GJ, Baguley BC: Effects of protein binding on the in vitro activity of antitumour acridine derivatives and related anticancer drugs. Cancer Chemother Pharmacol. 2000;45(5):417-22.
GroupsApproved; Investigational
Direct ClassificationAcridines
SMILESCOC1=C(NC2=C3C=CC=CC3=NC3=CC=CC=C23)C=CC(NS(C)(=O)=O)=C1
Pathways
PharmGKBPA10309
ChEMBLCHEMBL43